Structured evidence table for Boswellia Joint Function Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Boswellia Joint Function Randomized Trial | Historically, Boswellia extract has been used to treat pain associated with osteoarthritis, rheumatoid arthritis, and tendonitis. | 2 | Nirvanashetty S (2026) | High potency and water dispersible Boswellia extract reduces pain and inflammation in subjects with osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial. |
| Boswellia Joint Function Randomized Trial | Results OLNP-27 significantly (P Conclusion Based on the current study findings, it can be concluded that OLNP-27 is an effective and safe natural option for the management of symptoms associated with osteoarthritis of the knee. | 2 | Nirvanashetty S (2026) | High potency and water dispersible Boswellia extract reduces pain and inflammation in subjects with osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial. |
| Boswellia Joint Function Randomized Trial | Background Boswellia serrata, also known as Indian frankincense, is a medicinal plant that has been used since ancient times in the traditional Indian medicine system, Ayurveda. | 2 | Nirvanashetty S (2026) | High potency and water dispersible Boswellia extract reduces pain and inflammation in subjects with osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial. |
| Boswellia Joint Function Randomized Trial | It causes chronic pain, reduced mobility, and disability, affecting 607 million individuals worldwide, with nearly 46.6 million new cases annually []. | 4 | Muacevic Alexander (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion |
| Boswellia Joint Function Randomized Trial | 11 12 13 14 15 11 15 HLA-DRB1 HLA-DQB1 Genetic polymorphisms in sterol regulatory element-binding protein 2 (rs2228314) [], interleukin-6 (rs1800795) [], and resistin (RETN) [] in Indian and Pakistani cohorts and growth differentiation factor 5 (rs143383) [],, andin Thai populations [] are linked to OA risk. | 4 | Muacevic Alexander (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion |
| Boswellia Joint Function Randomized Trial | Need for expert opinion Despite growing clinical and mechanistic evidence for collagen supplementation in OA, several gaps and challenges remain in translating this knowledge into clinical practice, especially in the Indian subcontinent and Southeast Asia. | 4 | Muacevic Alexander (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion |
| Boswellia Joint Function Randomized Trial | 1 2 3 4 6 7 8 9 10 1 Osteoarthritis (OA) is the most prevalent degenerative joint disease globally and the second most common rheumatologic condition []. | 4 | Muacevic Alexander (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion |
Source documents